The thromboxane receptor antagonist NTP42 improves haemodynamics, inhibits remodelling, and restores function within the cardiopulmonary system in preclinical pulmonary arterial hypertension models
Event: ESC Congress 2021 - The Digital Experience
Topic: Pulmonary Hypertension
Session: Pulmonary circulation, pulmonary embolism, right heart failure e-posters
ESC 365 is supported by
